Online
|
|
sell for gains
Posted by :
arsunSell, Sell Sell, sell at this stage that market is going down time being ,it will go down to Rs.352 to 364 , then you can take entry for buy for target Rs 415 to 435...
NSE Announcements on Ranbaxy Labs
Posted by :
MMB MessengerRanbaxy Laboratories Ltd has submitted to the Exchange a copy of the Result of Postal Ballot. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Ranbaxy Labs
Posted by : MMB Messenger
Ranbaxy Laboratories Ltd has informed BSE that the members of the Company by way of Postal Ballot, have passed the following Ordinary Resolutions, with overwhelming majority:
1. Appointment of Mr. Malvinder Mohan Singh as Chairman, CEO & Managing Director for the period from December 19, 2008 to May 24, 2009 (the date he stepped down from the said positions); and
2. Appointment of Mr. Atul Sobti as Chief Executive Officer & Managing Director of the Company for a period of three years effective May 24, 2009....
sell for gains
Posted by : Guestthe stock has gone up sharply today. Will come down tomorrow. sell for decent gains...
buy for gains
Posted by : naugtyboythe coy is on good times after exit of malvinder who looted the japs...
Ranbaxy ties up with South Korean Firm
Posted by :
rddIt will reach 400-420 in the next couple of sessions.Hold on!...
Ranbaxy ties up with South Korean Firm
Posted by : pms.swastika
Ranbaxy ties up with South Korean Firm
Drug major Ranbaxy Laboratories has entered into a deal with South Korean biotech firm Medy-Tox for marketing its cosmetic product, Neuronox, in the Indian market.
Regards
Swastika PMS...
NSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed the Exchange regarding a press release dated September 17, 2009, titled "Ranbaxy in-licenses cosmetic product, Neuronox, from Medy - Tox, South Korea, for Indian market - Strengthens presence in Dermatological segment". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed BSE regarding a Press Release dated September 17 2009 titled "Ranbaxy in-licenses cosmetic product, Neuronox, from Medy-Tox, South Korea, for Indian market"...
buy for gains
Posted by : naugtyboyas predicted 2 days back-big moves seen ahead-buy for handsome gains...
target 375
Posted by : naugtyboythe share should reach 375 levels by sep series-good times r here again for this share...
BSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 26, 2009, inter alia, to consider Unaudited Financial Results (Provisional) for the third quarter ending September 30, 2009 (Q3)....
BSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed BSE that the auditors have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2009....
BSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed BSE regarding a Press Release dated September 03, 2009 titled "Ranbaxy Launches Authorized Generic Version of Rocaltrol". ...
NSE Announcements on Ranbaxy Labs
Posted by : MMB MessengerRanbaxy Laboratories Ltd has informed the Exchange regarding a press release dated September 03, 2009, titled "Ranbaxy Launches Authorized Generic Version of Rocaltrol". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
